Parkinson disease

被引：0

|

作者：

Keller, David L. ^{[1
]}

机构：

[1] Providence Med Inst, Torrance, CA USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2012年 / 79卷 / 04期

关键词：

RISK;

D O I：

10.3949/ccjm.79c:04006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：242 / 243

页数：2

相关论文

共 50 条

[1] PARKINSON DISEASE Is GDNF beneficial in Parkinson disease?
Hoffer, Barry J.
Harvey, Brandon K.
NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 600 - 602
[2] PARKINSON DISEASE Depression and anxiety in Parkinson disease
Martinez-Martin, Pablo
Damian, Javier
NATURE REVIEWS NEUROLOGY, 2010, 6 (05) : 243 - 245
[3] PARKINSON DISEASE Improving quality of care in Parkinson disease
Schmidt, Peter
Okun, Michael S.
NATURE REVIEWS NEUROLOGY, 2011, 7 (04) : 196 - 197
[4] PARKINSON DISEASE New guidelines for diagnosis of Parkinson disease
Jose Marti, Maria
Tolosa, Eduardo
NATURE REVIEWS NEUROLOGY, 2013, 9 (04) : 190 - 191
[5] PARKINSON DISEASE The controversy of levodopa toxicity in Parkinson disease
Zesiewicz, Theresa A.
NATURE REVIEWS NEUROLOGY, 2012, 8 (01) : 8 - 10
[6] Parkinson disease: Accurate noninvasive diagnosis of Parkinson disease
Casey J.
Nature Reviews Neurology, 2009, 5 (4) : 178 - 178
[7] PARKINSON DISEASE Calcium channel blockers and Parkinson disease
Pfeiffer, Ronald F.
NATURE REVIEWS NEUROLOGY, 2010, 6 (04) : 188 - 189
[8] Parkinson disease
Balestrino, R.
Schapira, A. H., V
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (01) : 27 - 42
[9] Parkinson Disease
Joseph, Claire B.
JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2023, 27 (02) : 221 - 224
[10] Parkinson Disease
Homayoun, Houman
ANNALS OF INTERNAL MEDICINE, 2018, 169 (05) : ITC33 - ITC47

← 1 2 3 4 5 →